Notice: This company has been marked as potentially delisted and may not be actively trading. Apexigen (APGNW) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Biotech Executive Meenu Chhabra Karson joins Bedford Group Transearch Advisory BoardJanuary 30, 2024 | finance.yahoo.comTrading was temporarily halted for "APGNW" at 07:08 PM with a stated reason of "News pending."August 23, 2023 | marketbeat.comAPEXIGEN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apexigen, Inc ...August 11, 2023 | businesswire.comLifshitz Law PLLC Announces Investigations of APGN, GNL, RTL, and BACKJune 3, 2023 | benzinga.comApexigen Stock (NASDAQ:APGN), Insider Trading ActivityMay 27, 2023 | benzinga.comApexigen (APGN) to Get Acquired by Pyxis Oncology, Stock UpMay 25, 2023 | msn.comEF Hutton Downgrades Apexigen (APGN)May 25, 2023 | msn.comBiotech Soars On Acquisition AnnouncementMay 24, 2023 | theglobeandmail.comSmall SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16MMay 24, 2023 | msn.comWhy Is Apexigen (APGN) Stock Up 31% Today?May 24, 2023 | investorplace.comUS Futures Lower as Investors Eye Debt Ceiling Talks, Await Fed Minutes ReleaseMay 24, 2023 | msn.comPyxis Oncology to Acquire ApexigenMay 24, 2023 | finance.yahoo.comApexigen surges ~40% on all-stock acquisition by Pyxis OncologyMay 24, 2023 | msn.comAPGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apexigen, Inc. Is Fair to ShareholdersMay 24, 2023 | technews.tmcnet.comMonths after going public, Peninsula biotech cuts staff, weights its options for futureFebruary 27, 2023 | bizjournals.comMonths after going public, Peninsula biotech Apexigen cuts staff, weighs its options for futureFebruary 27, 2023 | bizjournals.com Get Apexigen News Delivered to You Automatically Sign up to receive the latest news and ratings for APGNW and its competitors with MarketBeat's FREE daily newsletter. Email Address APGNW Media Mentions By Week APGNW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APGNW News Sentiment▼0.000.56▲Average Medical News Sentiment APGNW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APGNW Articles This Week▼00▲APGNW Articles Average Week Get Apexigen News Delivered to You Automatically Sign up to receive the latest news and ratings for APGNW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alpha Tau Medical News Apollomics News BriaCell Therapeutics News enGene News Fortress Biotech News GeoVax Labs News Lexaria Bioscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APGNW) was last updated on 2/10/2025 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon’s ‘Agents’ StrikeHe might be the richest man on the planet – but Elon Musk just landed himself a new job... In a move that c...Altimetry | SponsoredBill O’Reilly: “the best-prepared president in history.”"We're going to bring back the American Dream... bigger, better, bolder, richer, safer, and stronger than ever...The Oxford Club | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apexigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apexigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.